Skip to content
2000
Volume 15, Issue 1
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Rabies is a zoonose affecting wild and domestic animals and transmitted to humans through bites or scratches, causing over 60,000 human deaths, annually. The disease results from the transmission of a neurotropic virus leading to invariably deadly encephalitis. The post-exposure prophylaxis consists of careful washing and disinfection of the wound, antibiotherapy and tetanus prophylaxis when needed. Furthermore, rabies vaccine and rabies immunoglobulin [RIG] administration should be applied according to the type of wound, and the animal involved, according to the WHO protocols that are regularly updated. Unfortunately it is sometimes difficult to obtain RIG in some countries due to their high cost, leading to suboptimal treatment and possible death. Also, observance can be weak, due to the number of repeated visits required with protocols [up to five visits over 28 days]. These limitations justify research on new vaccines which were not conclusive at the moment. New RIGs are under development, including a monoclonal antibody cocktail which is more promising in a near future. Finally, vaccination protocols are in the way of being shortened in given conditions. Further studies are needed to validate these new practices.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/1871526515666150320161630
2015-03-01
2025-04-18
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/1871526515666150320161630
Loading

  • Article Type:
    Research Article
Keyword(s): Humans; post exposure prophylaxis; rabies; rabies immunoglobulin; recommendations; vaccines
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test